©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3852-3859
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3852
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3852
Table 1 Expression of integrin αvβ6 and MMP-9 and patient characteristics
| Characteristic | No. | αvβ6 | P value | MMP-9 | P value | ||
| Negative | Positive | Negative | Positive | ||||
| Age (yr) | |||||||
| < 60 | 51 | 33 | 18 | 31 | 20 | ||
| > 60 | 75 | 49 | 26 | 0.942 | 42 | 33 | 0.593 |
| Gender | |||||||
| Male | 78 | 50 | 28 | 43 | 35 | ||
| Female | 48 | 32 | 16 | 0.769 | 30 | 18 | 0.416 |
| Location | |||||||
| Upper | 27 | 20 | 7 | 16 | 11 | ||
| Middle | 51 | 28 | 23 | 28 | 23 | ||
| Lower | 48 | 34 | 14 | 0.136 | 29 | 19 | 0.847 |
| Lauren type | |||||||
| Intestinal | 83 | 47 | 36 | 46 | 37 | ||
| Diffuse | 43 | 35 | 8 | 0.006 | 27 | 16 | 0.427 |
| Differentiation | |||||||
| Well | 19 | 15 | 4 | 6 | 13 | ||
| Moderate | 30 | 14 | 16 | 18 | 12 | ||
| Poor | 77 | 53 | 24 | 0.038 | 49 | 28 | 0.039 |
| T stage | |||||||
| T1 | 14 | 10 | 4 | 3 | 11 | ||
| T2 | 13 | 7 | 6 | 8 | 5 | ||
| T3 | 18 | 10 | 8 | 14 | 4 | ||
| T4 | 81 | 55 | 26 | 0.578 | 48 | 33 | 0.014 |
| N stage | |||||||
| N0 | 37 | 26 | 11 | 18 | 19 | ||
| N1 | 17 | 12 | 5 | 10 | 7 | ||
| N2 | 26 | 10 | 16 | 11 | 15 | ||
| N3 | 46 | 34 | 12 | 0.016 | 34 | 12 | 0.033 |
| M stage | |||||||
| M0 | 124 | 81 | 43 | 73 | 51 | ||
| M1 | 2 | 1 | 1 | 0.652 | 0 | 2 | 0.094 |
| TNM stage | |||||||
| I | 12 | 4 | 8 | 3 | 9 | ||
| II | 42 | 36 | 6 | 22 | 20 | ||
| III | 70 | 41 | 29 | 48 | 22 | ||
| IV | 2 | 1 | 1 | 0.002 | 0 | 2 | 0.008 |
- Citation: Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. World J Gastroenterol 2016; 22(14): 3852-3859
- URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3852